0,990  0,001  Chemoprotective
0,977  0,001  Antimutagenic
0,973  0,002  Monophenol monooxygenase inhibitor
0,966  0,004  Alpha-glucosidase inhibitor
0,952  0,001  NOS2 expression inhibitor
0,947  0,002  Chemopreventive
0,943  0,002  UGT1A9 substrate
0,944  0,003  Mutagenic
0,937  0,002  Caspase 9 stimulant
0,933  0,002  Genotoxic
0,927  0,003  Antioxidant
0,925  0,001  Xanthine oxidase inhibitor
0,914  0,003  Antihypercholesterolemic
0,911  0,002  Proliferative diseases treatment
0,903  0,002  Antihypoxic
0,899  0,001  Melanin inhibitor
0,894  0,003  Vasodilator, coronary
0,892  0,003  Cardioprotectant
0,889  0,003  Radioprotector
0,887  0,004  TNF expression inhibitor
0,882  0,001  Amylase inhibitor
0,884  0,003  Free radical scavenger
0,884  0,004  Carcinogenic
0,877  0,002  UGT1A1 substrate
0,876  0,002  Carbonic anhydrase XIII inhibitor
0,873  0,008  Transcription factor NF kappa B inhibitor
0,857  0,002  Sulfotransferase substrate
0,853  0,005  Antidiabetic
0,853  0,005  Cyclophilin D inhibitor
0,849  0,002  Antihypotensive
0,847  0,010  Antiinflammatory
0,844  0,012  Apoptosis agonist
0,829  0,001  Antihemorrhagic
0,823  0,004  NOS3 expression inhibitor
0,824  0,004  Cytostatic
0,804  0,003  Mediator release inhibitor
0,808  0,009  Teratogen
0,794  0,004  DNA damaging
0,794  0,004  Hypoglycemic
0,792  0,004  Histamine release inhibitor
0,780  0,004  UDP-glucuronosyltransferase substrate
0,773  0,010  Embryotoxic
0,757  0,004  Angiogenesis stimulant
0,755  0,008  Respiratory analeptic
0,753  0,009  CYP2C9 substrate
0,747  0,006  Antibacterial
0,744  0,004  Skin whitener
0,745  0,005  Nitric oxide antagonist
0,730  0,002  Cystathionine beta-synthase inhibitor
0,726  0,005  AR expression inhibitor
0,717  0,007  Antithrombotic
0,712  0,005  Vascular (periferal) disease treatment
0,708  0,003  NOS3 expression enhancer
0,713  0,012  Antileukemic
0,703  0,004  Apoptosis antagonist
0,693  0,005  Caspase 3 stimulant
0,686  0,004  Antihypertriglyceridemic
0,688  0,007  Spasmolytic
0,685  0,005  Hepatic disorders treatment
0,686  0,009  CYP2C19 substrate
0,692  0,019  CYP3A4 substrate
0,675  0,007  Antiparasitic
0,670  0,004  Hepatoprotectant
0,663  0,003  Beta glucuronidase inhibitor
0,661  0,005  Amyloid beta aggregation inhibitor
0,660  0,005  Antiamyloidogenic
0,658  0,005  Ulceration
0,657  0,005  Antipruritic, allergic
0,652  0,011  Sensitization
0,641  0,005  Antihelmintic
0,638  0,007  UGT1A6 substrate
0,634  0,006  Hypoxia-inducible factor 1 alpha inhibitor
0,633  0,006  Tumour necrosis factor alpha release inhibitor
0,624  0,002  Protein kinase stimulant
0,621  0,008  Antipyretic
0,617  0,005  Antineoplastic (osteosarcoma)
0,619  0,012  Analeptic
0,632  0,030  Antineoplastic (breast cancer)
0,611  0,009  5 Hydroxytryptamine release inhibitor
0,600  0,004  Antidote
0,604  0,011  Cytotoxic
0,604  0,016  Immunostimulant
0,615  0,028  Antineoplastic (lung cancer)
0,581  0,003  Carbonic anhydrase III inhibitor
0,599  0,023  Antineoplastic (colorectal cancer)
0,576  0,003  Neurotrophic factor enhancer
0,575  0,004  VCAM1 expression inhibitor
0,564  0,004  UGT2B4 substrate
0,577  0,021  Prostate cancer treatment
0,561  0,005  ICAM1 expression inhibitor
0,558  0,003  Antifungal enhancer
0,554  0,004  Lipid peroxidase inhibitor
0,551  0,004  Aldehyde dehydrogenase inhibitor
0,554  0,008  RNA-directed DNA polymerase inhibitor
0,546  0,009  Vasodilator
0,535  0,002  Nitric-oxide synthase stimulant
0,559  0,026  Antineoplastic (colon cancer)
0,538  0,005  Topoisomerase II inhibitor
0,544  0,012  Antiprotozoal (Leishmania)
0,535  0,005  Non-steroidal antiinflammatory agent
0,533  0,004  Antitussive
0,543  0,015  Antifungal
0,543  0,019  CYP1A2 substrate
0,549  0,025  Cholesterol antagonist
0,524  0,003  Expectorant
0,538  0,017  Antineoplastic (pancreatic cancer)
0,537  0,022  5 Hydroxytryptamine release stimulant
0,532  0,019  Antineoplastic (cervical cancer)
0,517  0,006  Radiosensitizer
0,527  0,019  CTGF expression inhibitor
0,521  0,016  Antineoplastic (glioma)
0,502  0,002  Antiviral (Influenza B)
0,516  0,017  Antineoplastic (brain cancer)
0,499  0,004  UGT2B15 substrate
0,500  0,006  Interferon gamma antagonist
0,496  0,004  Aldose reductase substrate
0,503  0,012  Antineoplastic (lymphoma)
0,492  0,009  Antineoplastic (sarcoma)
0,485  0,003  AMP-activated protein kinase stimulant
0,507  0,031  Immunosuppressant
0,479  0,005  Hemostatic
0,477  0,003  Carbonic anhydrase VI inhibitor
0,478  0,005  Alkylator
0,480  0,011  Antineoplastic (liver cancer)
0,473  0,003  Cyclooxygenase 3 inhibitor
0,475  0,006  Platelet adhesion inhibitor
0,482  0,015  DNA synthesis inhibitor
0,475  0,008  Cyclic AMP phosphodiesterase inhibitor
0,494  0,028  Antineoplastic (ovarian cancer)
0,469  0,005  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,489  0,025  Antineoplastic (melanoma)
0,477  0,017  Antineoplastic (glioblastoma multiforme)
0,467  0,007  DNA methylase inhibitor
0,486  0,031  Stroke treatment
0,459  0,004  NADPH oxidase inhibitor
0,477  0,027  Immunomodulator
0,460  0,014  Interleukin 2 agonist
0,496  0,050  Alzheimer's disease treatment
0,454  0,010  Antiviral (Herpes)
0,446  0,003  Antihelmintic (Trematoda)
0,459  0,016  Antidiabetic symptomatic
0,447  0,005  Alkaline phosphatase inhibitor
0,444  0,005  Topoisomerase I inhibitor
0,445  0,005  Antipruritic, non-allergic
0,439  0,003  DNA repair enzyme inhibitor
0,463  0,034  Bone diseases treatment
0,430  0,007  DNA methyltransferase I inhibitor
0,421  0,004  Topoisomerase II alpha inhibitor
0,419  0,004  Alcohol dehydrogenase inhibitor
0,443  0,029  Antiosteoporotic
0,429  0,015  Interleukin agonist
0,414  0,005  UDP-glucose 4-epimerase inhibitor
0,423  0,018  Myocardial infarction treatment
0,407  0,003  Photosensitizer
0,439  0,036  CYP2D6 substrate
0,422  0,028  Antineoplastic (non-small cell lung cancer)
0,411  0,019  Antineoplastic enhancer
0,401  0,010  Antiviral (Influenza)
0,420  0,029  Antineoplastic (multiple myeloma)
0,417  0,028  Antidiabetic (type 2)
0,422  0,034  Antiischemic
0,386  0,005  Hexokinase inhibitor
0,384  0,003  Antiviral (Ebola)
0,382  0,005  Interleukin 4 antagonist
0,375  0,004  Selectin antagonist
0,372  0,010  Alpha-N-acetylglucosaminidase inhibitor
0,443  0,083  Antineoplastic (solid tumors)
0,409  0,052  Vasodilator, peripheral
0,376  0,025  Antineoplastic (small cell lung cancer)
0,357  0,011  Peptidyltransferase inhibitor
0,366  0,021  Septic shock treatment
0,351  0,015  UGT1A3 substrate
0,352  0,015  Antineoplastic (squamous cell carcinoma)
0,340  0,008  Antineoplastic antibiotic
0,356  0,027  Peroxidase inhibitor
0,334  0,005  Dementia treatment
0,331  0,005  Vascular dementia treatment
0,357  0,034  Antineoplastic (renal cancer)
0,351  0,029  Antiulcerative
0,323  0,004  Aldose reductase inhibitor
0,322  0,005  Antispirochetal
0,337  0,023  P-glycoprotein inhibitor
0,320  0,008  Carcinogenic, group 1
0,327  0,017  Carcinogenic, group 3
0,309  0,006  NADH dehydrogenase inhibitor
0,315  0,015  Antiviral (Influenza A)
0,322  0,022  UGT2B7 substrate
0,320  0,021  Thrombolytic
0,393  0,096  Antiarthritic
0,296  0,004  Histone deacetylase SIRT1 stimulant
0,296  0,004  Histone deacetylase stimulant
0,348  0,056  Antimycobacterial
0,300  0,009  Gout treatment
0,371  0,081  Antiprotozoal
0,300  0,010  Psychosexual dysfunction treatment
0,344  0,054  Lipoprotein disorders treatment
0,299  0,010  Antiprotozoal (Coccidial)
0,292  0,004  Heat shock protein 70 antagonist
0,301  0,013  Acute respiratory distress syndrome (ARDS) treatment
0,298  0,013  Insulin secretagoues
0,288  0,004  Carbonic anhydrase VII inhibitor
0,323  0,042  Pyruvate kinase inhibitor
0,289  0,014  Antidiarrheal
0,293  0,019  Antineoplastic (gastric cancer)
0,297  0,024  Antialcoholic
0,324  0,050  CYP1A2 inhibitor
0,284  0,011  Cell wall synthesis inhibitor
0,274  0,003  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,279  0,008  ATPase inhibitor
0,267  0,004  Phosphodiesterase VI inhibitor
0,262  0,004  Interleukin 12 antagonist
0,274  0,016  Glutathione S-transferase substrate
0,260  0,004  Carbonic anhydrase XIV inhibitor
0,264  0,009  Mannose-6-phosphate isomerase inhibitor
0,272  0,019  Interleukin 6 antagonist
0,256  0,008  Antineoplastic, alkylator
0,310  0,064  Aldehyde oxidase inhibitor
0,260  0,015  Chelator
0,250  0,006  Mucolytic
0,257  0,016  DNA polymerase I inhibitor
0,268  0,027  Antineoplastic (carcinoma)
0,244  0,004  Phosphodiesterase 6D inhibitor
0,246  0,007  Triose-phosphate isomerase inhibitor
0,243  0,010  Antibiotic
0,280  0,051  Antineoplastic (lymphocytic leukemia)
0,283  0,054  Antineoplastic (bladder cancer)
0,253  0,027  Muscular dystrophy treatment
0,247  0,021  Antineoplastic (bone cancer)
0,253  0,030  Antihelmintic (Nematodes)
0,237  0,015  Carcinogenic, group 2B
0,239  0,018  DNA intercalator
0,298  0,078  Antineoplastic (endocrine cancer)
0,237  0,018  SULT1A3 substrate
0,227  0,009  Uric acid excretion stimulant
0,216  0,003  Antibiotic Glycopeptide-like
0,257  0,046  Wound healing agent
0,223  0,013  Choleretic
0,215  0,007  Thioredoxin inhibitor
0,217  0,010  Phosphofructokinase-1 inhibitor
0,211  0,005  Toll-Like receptor 4 antagonist
0,276  0,071  Huntington's disease treatment
0,213  0,008  NAD(P)H dehydrogenase (quinone) inhibitor
0,260  0,058  Interleukin antagonist
0,209  0,008  Carcinogenic, group 2A
0,314  0,115  CYP2C19 inhibitor
0,214  0,015  CF transmembrane conductance regulator agonist
0,219  0,021  Antirickettsial
0,200  0,004  Fatty acid synthase inhibitor
0,211  0,018  Retinoprotector
0,210  0,017  Antifungal (Cryptococcus)
0,236  0,043  Insulin sensitizer
0,225  0,038  Protein-tyrosine phosphatase inhibitor
0,193  0,008  Estrogen agonist
0,193  0,009  Carbonic anhydrase XII inhibitor
0,262  0,079  Transcription factor STAT inhibitor
0,193  0,012  Multidrug resistance-associated protein 1 inhibitor
0,211  0,030  Acetylcholinesterase inhibitor
0,187  0,007  Interferon agonist
0,212  0,034  Neuropathy treatment
0,191  0,012  Antineoplastic (uterine cancer)
0,188  0,010  HIV-1 integrase (3'-Processing) inhibitor
0,196  0,026  Adenylate cyclase inhibitor
0,199  0,029  Protein-tyrosine phosphatase 1B inhibitor
0,197  0,030  MAO A inhibitor
0,180  0,014  Creatine kinase inhibitor
0,185  0,019  UGT2B1 substrate
0,232  0,067  Antiviral (HIV)
0,179  0,015  Chronic obstructive bronchitis treatment
0,169  0,005  Xanthine dehydrogenase inhibitor
0,239  0,077  Platelet antagonist
0,163  0,002  Sodium/glucose cotransporter inhibitor
0,168  0,013  Transcription factor NF kappa B stimulant
0,166  0,011  Postmenopausal disorders treatment
0,165  0,011  SULT1E1 substrate
0,197  0,043  Cyclooxygenase inhibitor
0,170  0,018  Estrogen antagonist
0,169  0,017  Sphingomyelinase inhibitor
0,176  0,025  SULT1A1 substrate
0,159  0,009  Interleukin 5 antagonist
0,205  0,054  Diabetic nephropathy treatment
0,228  0,078  Hypolipemic
0,161  0,012  HIV-1 integrase (Strand Transfer) inhibitor
0,151  0,002  Sodium/glucose cotransporter 1 inhibitor
0,214  0,065  Sedative
0,151  0,002  Cholesterol absorption inhibitor
0,177  0,032  Cell adhesion inhibitor
0,150  0,006  Na+ K+ transporting ATPase inhibitor
0,175  0,034  Antiviral (Hepatitis B)
0,148  0,008  Antiviral (Dengue virus)
0,163  0,024  HDL-cholesterol increasing
0,271  0,132  Antineoplastic (non-Hodgkin's lymphoma)
0,139  0,002  Sodium/glucose cotransporter 2 inhibitor
0,165  0,031  Growth stimulant
0,224  0,090  Aryl hydrocarbon receptor agonist
0,137  0,004  Alpha-mannosidase inhibitor
0,172  0,041  Cyclooxygenase 2 inhibitor
0,168  0,038  Adenylate cyclase stimulant
0,160  0,030  Vanilloid 1 agonist
0,132  0,005  Antimycoplasmal
0,225  0,099  Antiprotozoal (Trypanosoma)
0,130  0,004  Mannosidase inhibitor
0,156  0,032  Gastritis treatment
0,179  0,054  Diuretic
0,126  0,003  Arginase inhibitor
0,130  0,010  Neuraminidase (influenza) inhibitor
0,177  0,061  Eye irritation, high
0,129  0,015  ATPase (Vacuolar H+) inhibitor
0,154  0,043  Antibacterial (Helicobacter pylori)
0,144  0,034  Falcipain inhibitor
0,142  0,032  Falcipain 2 inhibitor
0,159  0,052  Cyclooxygenase 1 inhibitor
0,114  0,008  Topoisomerase II beta inhibitor
0,185  0,081  VEGF expression inhibitor
0,128  0,024  Telomerase inhibitor
0,130  0,027  Protein kinase C zeta inhibitor
0,138  0,036  Carbonic anhydrase XV inhibitor
0,113  0,011  Neuraminidase inhibitor
0,105  0,004  Glucose-6-phosphate isomerase inhibitor
0,151  0,052  Toll-Like receptor 2 antagonist
0,109  0,010  Interferon inducer
0,214  0,116  Antituberculosic
0,172  0,073  Liver fibrosis treatment
0,176  0,078  Diabetic retinopathy treatment
0,170  0,072  Phospholipase C inhibitor
0,124  0,027  Estrogen receptor beta antagonist
0,122  0,025  Antiviral (Trachoma)
0,130  0,033  Breast cancer-resistant protein inhibitor
0,106  0,011  Estrogen receptor beta agonist
0,098  0,003  Antibiotic Aminoglycoside-like
0,175  0,081  Antiviral (Hepatitis)
0,223  0,130  Metabolic disease treatment
0,110  0,018  Narcotic antagonist
0,095  0,003  Protein 30S ribosomal subunit inhibitor
0,167  0,075  UGT1A4 substrate
0,103  0,012  Protein 50S ribosomal subunit inhibitor
0,094  0,004  Heparanase inhibitor
0,102  0,014  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,121  0,034  UGT2B11 substrate
0,147  0,062  Neurotrophic factor
0,108  0,023  Lipase inhibitor
0,174  0,091  Anesthetic general
0,134  0,053  Papain-like protease (SARS coronavirus) inhibitor
0,161  0,080  UGT2B10 substrate
0,150  0,068  Antidiabetic (type 1)
0,099  0,017  Protein kinase C eta inhibitor
0,103  0,022  T cell inhibitor
0,134  0,054  Beta amyloid protein antagonist
0,104  0,025  Thioredoxin reductase inhibitor
0,087  0,009  Glucose-6-phosphate translocase inhibitor
0,141  0,064  MAO inhibitor
0,256  0,179  Antiparkinsonian
0,095  0,018  Antidote, heavy metal
0,095  0,019  Maillard reaction inhibitor
0,221  0,147  Angiogenesis inhibitor
0,130  0,057  Cholesterol synthesis inhibitor
0,151  0,085  Cystic fibrosis treatment
0,093  0,029  HIV-1 integrase inhibitor
0,080  0,017  Phosphorylase inhibitor
0,145  0,083  Antinephritic
0,168  0,107  Cardiodepressant
0,104  0,044  Antiviral (Rhinovirus)
0,113  0,053  DOPA decarboxylase inhibitor
0,153  0,093  Dual specificity phosphatase 3 inhibitor
0,087  0,028  Antitreponemal
0,109  0,053  Anticataract
0,074  0,018  Leukotriene B4 antagonist
0,090  0,034  CDC25A inhibitor
0,138  0,083  Ca2+-transporting ATPase inhibitor
0,134  0,080  Hair growth stimulant
0,148  0,096  Dual specificity phosphatase inhibitor
0,066  0,014  Estrogen receptor alpha agonist
0,079  0,027  DNA gyrase inhibitor
0,076  0,026  Nitric oxide donor
0,194  0,147  Lipoxygenase inhibitor
0,126  0,080  Contraceptive
0,156  0,111  Psychostimulant
0,062  0,017  Equilibrative nucleoside transport protein inhibitor
0,083  0,040  Histidine decarboxylase inhibitor
0,062  0,019  Adenosine deaminase inhibitor
0,098  0,056  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,084  0,042  GABA aminotransferase inhibitor
0,116  0,074  M18 aspartyl aminopeptidase inhibitor
0,043  0,004  Vanilloid 2 agonist
0,112  0,075  Transcription factor STAT6 inhibitor
0,118  0,083  Antiacne
0,096  0,062  Antischistosomal
0,061  0,027  Adenine nucleotide translocase inhibitor
0,081  0,047  Estrogen receptor alpha antagonist
0,117  0,088  Bone formation stimulant
0,191  0,162  12-Lipoxygenase inhibitor
0,051  0,022  Neuraminidase (Influenza A) inhibitor
0,127  0,099  Cholinergic
0,185  0,157  Transcription factor STAT3 inhibitor
0,061  0,034  Lipocortins synthesis agonist
0,029  0,004  Antibiotic Anthracycline-like
0,029  0,003  Telomerase stimulant
0,047  0,022  DNA gyrase subunit A inhibitor
0,140  0,115  Hearing loss treatment
0,053  0,029  Factor III inhibitor
0,220  0,197  Atherosclerosis treatment
0,031  0,010  Toll-Like receptor 4 agonist
0,031  0,011  1,3-Beta-glucan synthase inhibitor
0,036  0,016  Protein kinase C beta I inhibitor
0,108  0,089  Alcohol dehydrogenase substrate
0,068  0,049  Carbonic anhydrase VA inhibitor
0,087  0,069  Glutamate release inhibitor
0,083  0,064  Ornithine decarboxylase inhibitor
0,085  0,067  Aminoacyl-tRNA synthetase inhibitor
0,063  0,046  CDC25B inhibitor
0,062  0,045  Carbonic anhydrase inhibitor
0,086  0,070  Restless leg syndrome treatment
0,077  0,061  Glycine receptor antagonist
0,205  0,190  Antiprotozoal (Plasmodium)
0,222  0,210  DNA directed DNA polymerase inhibitor
0,024  0,014  Dopamine D1 agonist
0,033  0,022  Estrogen-related receptor beta antagonist
0,071  0,061  SULT1A2 substrate
0,025  0,016  Adenosine A1 receptor agonist
0,100  0,093  Aldehyde dehydrogenase substrate
0,099  0,093  Microtubule formation inhibitor
0,060  0,054  Aryl hydrocarbon receptor antagonist
0,104  0,098  Constipation treatment
0,046  0,041  Cytokine production stimulant
0,081  0,076  Actinic keratosis treatment
0,030  0,025  Nucleoside transporters inhibitor
0,149  0,145  Pneumotoxic
0,059  0,056  Carbonic anhydrase V inhibitor
0,021  0,018  GRP78 expression inhibitor
0,010  0,008  Purinergic P2Y2 agonist
0,118  0,117  Heat shock protein 90 antagonist
0,029  0,028  Melatonin 2 agonist

